Clinical Takeaway CBD alone does not directly reduce brain electrical activity or cause sedation in healthy individuals at doses up to 700 mg, suggesting its anti-seizure effects in clinical use arise primarily...
Cannabidiol & Cortical Excitability: Clinical Trial Findings
Clinical Takeaway In this randomized controlled trial, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation in healthy adults,...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized controlled trial, neither a low nor high single dose of CBD directly reduced cortical excitability or produced measurable sedation in healthy adults. These findings suggest that CBD's...
endocannabinoid system: CBD & Cortical Excitability Trial
Clinical Takeaway In this randomized controlled trial, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation in healthy volunteers,...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this controlled trial of healthy adults, neither a low nor a high single dose of CBD directly altered cortical excitability compared to placebo, suggesting CBD may not have meaningful...
Cannabidiol & Cortical Excitability: Clinical Trial Results
Clinical Takeaway In a controlled crossover trial of healthy males, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability compared to...
Cannabinoid Clinical Trials: CBD and Cortical Excitability
Clinical Takeaway In a controlled crossover trial of healthy men, neither a low (30 mg) nor a high (700 mg) single dose of CBD directly altered cortical excitability compared to placebo. This...
`Cannabidiol & Cortical Excitability: Clinical Trial Findings`
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy adults, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy males, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
`Cannabidiol & Cortical Excitability: Clinical Trial Evidence`
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high single doses failed to directly reduce cortical excitability compared to placebo, suggesting its anti-seizure effects may...